inulin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
1447 9005-80-5

Description:

MoleculeDescription

Synonyms:

  • inulin
A starch found in the tubers and roots of many plants. Since it is hydrolyzable to FRUCTOSE, it is classified as a fructosan. It has been used in physiologic investigation for determination of the rate of glomerular function.
  • Molecular weight:
  • Formula: C7H14O5(C6H10O5)n
  • CLOGP: -3.98
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

None

Approvals:

DateAgencyCompanyOrphan
Aug. 25, 2021 PMDA FUJI YAKUHIN Co., Ltd
April 30, 1940 FDA ISO TEX

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC V04CH01 VARIOUS
DIAGNOSTIC AGENTS
OTHER DIAGNOSTIC AGENTS
Tests for renal function and ureteral injuries
CHEBI has role CHEBI:55323 antidiarrhoeal drug
CHEBI has role CHEBI:74518 anti-obesity agent

Related Drugs by ATC class:

V04CH Tests for renal function and ureteral injuries 4 drugs
alsactideaminohippuric acidindigo carminephenolsulfonphthalein

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Renal function study indication 44277000
Constipation contraindication 14760008 DOID:2089
Hyperphosphatemia contraindication 20165001 DOID:0050459
Hypervitaminosis D contraindication 27712000 DOID:9971
Sarcoidosis contraindication 31541009 DOID:11335
Dehydration contraindication 34095006
Hypercalcemia contraindication 66931009 DOID:12678
Hyperparathyroidism contraindication 66999008 DOID:13543
Kidney disease contraindication 90708001 DOID:557
Kidney stone contraindication 95570007
Osteolysis contraindication 203522001
Arteriosclerosis obliterans contraindication 361133006 DOID:5160




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
4018838 VUID
N0000147140 NUI
D00171 KEGG_DRUG
4018838 VANDF
C0021936 UMLSCUI
CHEBI:15443 CHEBI
CHEMBL1201646 ChEMBL_ID
DB00638 DRUGBANK_ID
JOS53KRJ01 UNII
5924 RXNORM
17140 MMSL
d04848 MMSL
002342 NDDF
D007444 MESH_DESCRIPTOR_UI

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
JBA Verestor Mega Fiber Powder HUMAN OTC DRUG LABEL 8 13411-862 POWDER 1500 mg ORAL unapproved drug other 6 sections
JBA Verestor Mega Fiber Caffe Latte HUMAN OTC DRUG LABEL 5 13411-863 POWDER 1000 mg ORAL unapproved drug other 6 sections
Livita Adults HUMAN PRESCRIPTION DRUG LABEL 17 59088-659 LIQUID 500 mg ORAL unapproved drug other 10 sections
Livita Children HUMAN PRESCRIPTION DRUG LABEL 17 59088-660 LIQUID 166.67 mg ORAL unapproved drug other 10 sections